Assistance Request Form

The Tennessee Clinical and Translational Science Institute (TN-CTSI) offers a wealth of training and consultation opportunities to help researchers. The TN-CTSI can connect you to the expertise that will help you improve your grant scores, conduct a successful study, and increase the impact of your science. To request assistance from the TN-CTSI, please complete the Assistance Requested Form below.

Instructions: Please fill out this form as completely as possible so that we can understand what type of assistance you need. Items marked with an asterisk(*) are required.

    What category best describes you?*

    Areas of Assistance

    The Tennessee Clinical and Translational Science Institute (TN-CTSI) provides assistance in a number of
    areas. Please check all the areas you are requesting assistance.

    You selected:
    • Biostatistics
    • Clinical research support
    • Clinical research units

    Please provide your IRB or IACUC approval number below.

    Study Details

    What is the title of your project?

    Funding

    What is your funding source?*

    Type of Study

    Check all that apply.

    Study Phase

    Please provide information about the study details*

    Phase I: Clinical trials test a new experimental drug, biomedical or behavioral intervention in a small group of people for the first time to determine the efficacy and evaluate safety (e.g. determine a safe dosage range and identify side effects).
    Ib/II: Clinical trials give an experimental drug, biomedical or behavioral treatment to a larger group of people to determine the efficacy and to further evaluate its safety.
    III: Clinical trials determine the efficacy of an experimental drug, biomedical or behavioral intervention in large groups of people by comparing the intervention to other standard or experimental interventions as well as to monitor adverse effects, and to collect information that will allow the interventions to be used safely.
    IV: Clinical trials are post-marketing studies, which are conducted after a treatment is approved for use by the FDA, provide additional information including the treatment or drug’s risks, benefits, and best use).
    Not a Clinical Trial: The study is not a clinical trial. It is an observational study such as a cohort, cross-sectional, or case-control study.
    Unknown study type: Unknown what type of study this will be.
    Other: Unknown what type of study this will be.

    Has your study been initiated?*